< Back to all Breaking News
IPIX
1/24/2020 11:01am
Innovation completes dosing in Phase 1 trial of Brilacidin 
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.
